Organon & Co. Common Stock vs Western Digital Corp — how do they compare? Organon & Co. Common Stock trades at $13.77 (market cap $3.61B), while Western Digital Corp trades at $342.12 (market cap $136.29B). The key difference: Western Digital Corp is far larger — about 37.8× Organon & Co. Common Stock's market cap, and Organon & Co. Common Stock pays the higher dividend (0.58%). Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Western Digital Corp for 38 Days on average.
| OGN | WDC | |
|---|---|---|
Market Cap | $3.61B | $136.29B |
Volume | 1,808,049 | 6,718,334 |
Sector | Health | Technology |
52-Week High | $13.81 | $746.23 |
52-Week Low | $5.70 | $120.44 |
Typical Hold Time | 0 Days | 38 Days |
Enterprise Value | $11.03B | $135.76B |
Dividend Yield | 0.58% | 0.16% |
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Western Digital (WDC) trades at $380.71, down 1.61% amid recent volatility driven by news of Toshiba's planned HDD capacity expansion. The stock shows strong fundamentals with a P/E of 13.53 and net income margin of 71.97% for 2025, supported by three consecutive quarterly earnings beats. Technical indicators are mixed, with a bearish moving average signal but oversold RSI levels suggesting potential near-term support.
Outlook remains positive long-term given WDC's leadership in AI storage and robust analyst consensus (72% buy ratings, $643 price target), but near-term risks include increased competition and pricing pressure. The stock's current valuation presents an opportunity if execution continues, though investors should monitor competitive dynamics and margin trends closely.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →